AMENDED AND RESTATED DEVELOPMENT AGREEMENTDevelopment Agreement • August 1st, 2024 • Tandem Diabetes Care Inc • Surgical & medical instruments & apparatus • California
Contract Type FiledAugust 1st, 2024 Company Industry JurisdictionThis Amended and Restated Development Agreement (this “Agreement”) is made and entered into effective as of May 21, 2024 (“Effective Date”) by and between Tandem Diabetes Care, Inc, having a principal place of business at 12400 High Bluff Drive, San Diego, CA 92130 (“Tandem”) and DexCom, Inc., a Delaware corporation having a principal place of business at 6340 Sequence Drive, San Diego, CA 92121 (“DexCom”). Tandem and DexCom may be referred to in this Agreement individually as a “Party” and collectively as the “Parties.”
AMENDED AND RESTATED COMMERCIALIZATION AGREEMENTAmended And • August 1st, 2024 • Tandem Diabetes Care Inc • Surgical & medical instruments & apparatus • California
Contract Type FiledAugust 1st, 2024 Company Industry JurisdictionThis Amended and Restated Commercialization Agreement (this “Agreement”) is made and entered into effective as of May 21, 2024 (“Effective Date”) by and between Tandem Diabetes Care, Inc, having a principal place of business at 12400 High Bluff Drive, San Diego, CA 92130 (“Tandem”), and DexCom, Inc., a Delaware corporation having a principal place of business at 6340 Sequence Drive, San Diego, CA 92121 (“DexCom”). Tandem and DexCom may be referred to in this Agreement individually as a “Party” and collectively as the “Parties”.
EMPLOYMENT SEVERANCE AGREEMENTEmployment Severance Agreement • August 1st, 2024 • Tandem Diabetes Care Inc • Surgical & medical instruments & apparatus • California
Contract Type FiledAugust 1st, 2024 Company Industry JurisdictionThis Employment Severance Agreement (the “Agreement”) is made and entered into effective as of June 21, 2024 (the “Effective Date”), by and between Jean-Claude Kyrillos (the “Employee”) and Tandem Diabetes Care, Inc. (the “Company”).
Amendment No. 1 to Distributor Agreement Unomedical a/s and Tandem Diabetes Care, Inc.Distributor Agreement • August 1st, 2024 • Tandem Diabetes Care Inc • Surgical & medical instruments & apparatus
Contract Type FiledAugust 1st, 2024 Company IndustryThis amendment ( “Amendment No. 1”) is entered into effective as of May 8, 2024 (the “Amendment Effective Date”) by and between Unomedical a/s, a Danish corporation having its principal place of business at Aaholmvej 1-3, Osted, 4320 Lejre, Denmark (“Company”), and Tandem Diabetes Care, Inc., a Delaware corporation having its principal place of business at 12400 High Bluff Drive, San Diego, California, 92130, USA (“Distributor”) (each individually a “Party” and collectively the “Parties”).